Diabetes and Covid-19: Diabetes research funding and support during the pandemic.
Diabetes Res Clin Pract
; 198: 110597, 2023 Apr.
Article
in English
| MEDLINE | ID: covidwho-2262897
ABSTRACT
AIMS:
Between late 2020 and early 2022, EURADIA undertook a survey of organisations and individuals supporting or working in the field of diabetes research with the aim of understanding better the impact of the Covid-19 pandemic on funding for diabetes research in Europe.METHODS:
Information was collected via online survey augmented in some cases by face-to-face interviews.RESULTS:
Findings were mixed but the majority of those responding suggested a moderate impact of the pandemic on diabetes research activity. Many respondents reported a reduction in funding during the pandemic and many of those involved in clinical research experienced a reduction in research clinicians' availability for diabetes research as they were redeployed to Covid-19 patient care. It was frequently reported that the impact might not be fully appreciated until several years after the end of the pandemic.CONCLUSIONS:
This preliminary survey suggests there may be a significant impact of the pandemic on all aspects of diabetes research and that a more detailed follow-up on the impact of the pandemic on funding of diabetes research should be carried out in the future.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Diabetes Mellitus
/
COVID-19
Type of study:
Cohort study
/
Observational study
/
Prognostic study
/
Qualitative research
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Diabetes Res Clin Pract
Journal subject:
Endocrinology
Year:
2023
Document Type:
Article
Affiliation country:
J.diabres.2023.110597
Similar
MEDLINE
...
LILACS
LIS